We are live on
!
Find out more
MCP
Martin Capital Partners Portfolio holdings
AUM
$272M
1-Year Est. Return
19.09%
This Fund
S&P 500
This Quarter
Est. Return
-4.46%
1 Year Est. Return
+19.09%
3 Year Est. Return
+35.19%
5 Year Est. Return
+47.96%
10 Year Est. Return
–
AUM
$84.3M
AUM Growth
-$118M
(-58%)
Cap. Flow
-$113M
Cap. Flow
% of AUM
-133.8%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
74
New
5
Increased
–
Reduced
52
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Reinsurance Group of America
RGA
|
+$1.82M |
| 2 |
ASML
ASML
|
+$1.65M |
| 3 |
LyondellBasell Industries
LYB
|
+$1.31M |
| 4 |
Nike
NKE
|
+$1.24M |
| 5 |
State Street SPDR S&P Dividend ETF
SDY
|
+$425K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Entergy
ETR
|
+$4.79M |
| 2 |
MSC Industrial Direct
MSM
|
+$4.17M |
| 3 |
Cullen/Frost Bankers
CFR
|
+$4.14M |
| 4 |
Merck
MRK
|
+$4.11M |
| 5 |
Lockheed Martin
LMT
|
+$3.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.07% |
| 2 | Technology | 12.76% |
| 3 | Healthcare | 11.94% |
| 4 | Consumer Staples | 10.68% |
| 5 | Industrials | 10.44% |
Similar funds
SC
SC
BLAM
TP
AGP
SFPG
S
SS
Martin Capital Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Martin Capital Partners held 74 positions worth $84.3M, down 58% from $202M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Martin Capital Partners withdrew a net $113M in Q4 2024, closing 16 positions and reducing 52 holdings. Its most notable exit was Merck, an estimated $4.11M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Martin Capital Partners opened a new position in Reinsurance Group of America worth $1.79M.
- Martin Capital Partners's largest Q4 2024 buy was Reinsurance Group of America: 8,370 shares worth $1.79M.
- Martin Capital Partners's biggest Q4 2024 reduction was Entergy, cutting an estimated $4.79M.
- Martin Capital Partners fully exited Merck in Q4 2024, selling an estimated $4.11M.
- Martin Capital Partners's ten largest holdings make up 32% of its $84.3M portfolio in Q4 2024.
- Martin Capital Partners opened 5 new positions and closed 16 in Q4 2024.
- Martin Capital Partners's portfolio value fell 58% quarter-over-quarter to $84.3M.
Based on Martin Capital Partners's 13F filing for Q4 2024, filed 27 Jan 2025.